Eswar Therapeutics Private Limited - Company Profile

It is a pharma private limited company based in Chandigarh, Chandigarh, India, established in 2017.
2017 Chandigarh, Chandigarh, India Active
Last Updated:
Access Report
About Eswar Therapeutics Private Limited

Eswar Therapeutics Private Limited, a active private limited company, was established on 05 April 2017 in Chandigarh, Chandigarh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24304CH2017PTC041467. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Employing 140 professional, Its leadership includes Kashmiri Lal Khunger (Director), Vikram Khungar (Managing Director), Raj Khurana (Director). Past directors included Dipty Manchanda, Rajat Kaher, Kashmiri Lal Khunger. It holds ₹5.19 Cr open charges and ₹1.69 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 4-A, Raipur Kalan,, Chandigarh, Chandigarh, 160102.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304CH2017PTC041467

  • Registration Number

    041467

  • Incorporation Date

    05 April 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.19 Cr
  • Satisfied Charges ₹ 1.69 Cr
  • Revenue Growth **** 37.46%
  • Profit Growth **** 45.02%
  • Ebitda **** 38.01%
  • Net Worth 50.15%
  • Total Assets **** 44.44%
Company report

Eswar Therapeutics Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Eswar Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Eswar Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Kashmiri Lal Khunger Director 28 Nov 2023 Current
Vikram Khungar Managing Director 25 Jan 2019 Current
Raj Khurana Director 01 Apr 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 21 Nov 2023 Past
Pramod Abcsdd Director 25 Feb 2022 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Director 31 Mar 2025 Past
Pramod Abcsdd Director 25 May 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eswar Therapeutics.

Eswar Therapeutics Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 37.46% increase. The company also saw a substantial improvement in profitability, with a 45.02% increase in profit. The company's net worth Soared by an impressive increase of 50.15%.

Eswar Therapeutics revenue growth over time
Eswar Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 37.46%
*******
*******
*******
*******
Revenue from Operations
*******
 37.54%
*******
*******
*******
*******
Total Assets
*******
 44.44%
*******
*******
*******
*******
Profit or Loss
*******
 45.02%
*******
*******
*******
*******
Net Worth
*******
 50.15%
*******
*******
*******
*******
EBITDA
*******
 38.01%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eswar Therapeutics?

In 2024, Eswar Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹51,862,639.00

Satisfied Charges

₹16,895,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 4.66 Cr
  • Uco Bank : 0.40 Cr
  • Indian Overseas Bank : 0.12 Cr
Latest Charge Details
Date Lender Amount Status
30 Aug 2025 Indian Overseas Bank ₹1.20 M Open
28 Jul 2025 Hdfc Bank Limited ₹0.58 M Open
29 May 2025 Hdfc Bank Limited ₹0.72 M Open
21 Feb 2025 Hdfc Bank Limited ₹0.84 M Open
16 Dec 2024 Hdfc Bank Limited ₹0.70 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Eswar Therapeutics?

Eswar Therapeutics has a workforce of 140 employees as of Jan 22, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eswar Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eswar Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eswar Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    The activity Eswar Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with Indian Overseas Bank amounted to Rs. 1.20 M with Charge ID 101174374 was registered on 30 Aug 2025. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.58 M with Charge ID 101135228 was registered on 28 Jul 2025. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.72 M with Charge ID 101104160 was registered on 29 May 2025. was documented.

  • Balance Sheet

    Eswar Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.84 M with Charge ID 101052220 was registered on 21 Feb 2025. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Eswar Therapeutics Private Limited?

The CIN of Eswar Therapeutics Private Limited is U24304CH2017PTC041467.

Where is Eswar Therapeutics Private Limited headquartered?

Eswar Therapeutics Private Limited is headquartered at Plot No. 4-A, Raipur Kalan,, Chandigarh, Chandigarh, 160102.

When was Eswar Therapeutics Private Limited incorporated?

Eswar Therapeutics Private Limited was incorporated on 05 April 2017.

Who are the current directors of Eswar Therapeutics Private Limited?

The current directors of Eswar Therapeutics Private Limited are

What is the primary industry of Eswar Therapeutics Private Limited?

The primary industry of Eswar Therapeutics Private Limited is Trade.

Is Eswar Therapeutics Private Limited a listed company?

Eswar Therapeutics Private Limited is unlisted.

What is the capital structure of Eswar Therapeutics Private Limited?

The authorized capital of Eswar Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Eswar Therapeutics Private Limited?

The compliance status of Eswar Therapeutics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available